Alaunos Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRT and other ETFs, options, and stocks.About TCRT
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy.
CEOHolger Weis
CEOHolger Weis
Employees1
Employees1
HeadquartersFort Lauderdale, Florida
HeadquartersFort Lauderdale, Florida
Founded2003
Founded2003
Employees1
Employees1
TCRT Key Statistics
Market cap9.08M
Market cap9.08M
Price-Earnings ratio-1.73
Price-Earnings ratio-1.73
Dividend yield—
Dividend yield—
Average volume66.90K
Average volume66.90K
High today$4.11
High today$4.11
Low today$3.90
Low today$3.90
Open price$3.95
Open price$3.95
Volume15.70K
Volume15.70K
52 Week high$6.20
52 Week high$6.20
52 Week low$1.31
52 Week low$1.31
Stock Snapshot
The current Alaunos Therapeutics(TCRT) stock price is $4.07, with a market capitalization of 9.08M. The stock trades at a price-to-earnings (P/E) ratio of -1.73.
As of 2025-12-10, Alaunos Therapeutics(TCRT) stock has fluctuated between $3.90 and $4.11. The current price stands at $4.07, placing the stock +4.4% above today's low and -1.0% off the high.
Alaunos Therapeutics(TCRT) shares are trading with a volume of 15.7K, against a daily average of 66.9K.
During the past year, Alaunos Therapeutics(TCRT) stock moved between $1.31 at its lowest and $6.20 at its peak.
During the past year, Alaunos Therapeutics(TCRT) stock moved between $1.31 at its lowest and $6.20 at its peak.
People also own
Based on the portfolios of people who own TCRT. This list is generated using Robinhood data, and it’s not a recommendation.